NovoCure Ltd — Director's Dealing 2016

Feb 26, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2016-02-24

Reporting Person: Kirson Eilon D. (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-24	Options to Buy Ordinary Shares	$11.46	A	75000	Acquired	2026-02-24	Ordinary Shares (75000)	Direct

Footnotes

F1: Options to buy 75,000 ordinary shares will vest and become exercisable in equal installments on each of February 24, 2017, 2018, 2019 and 2020, subject to Mr. Kirson's continued employment through such dates.